Target- And Resistance-Based Mechanistic Studies With TP-434, a Novel Fluorocycline Antibiotic

Antimicrobial Agents and Chemotherapy - United States
doi 10.1128/aac.06187-11
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society for Microbiology

Related search

Antibacterial Activity of Eravacycline (TP-434), a Novel Fluorocycline, Against Hospital and Community Pathogens

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2013English

The Bacterial Mecanosensitive Channel MscL as a Novel Antibiotic Target

Biophysical Journal
Biophysics
2019English

Structural Studies of a Novel Macrolide Antibiotic, Notonesomycin A.

NIPPON KAGAKU KAISHI
1986English

AMPD1: A Novel Therapeutic Target for Reversing Insulin Resistance

BMC Endocrine Disorders
MedicineEndocrinologyMetabolismDiabetes
2014English

A Target-Protection Mechanism of Antibiotic Resistance at Atomic Resolution: Insights Into FusB-type Fusidic Acid Resistance

Scientific Reports
Multidisciplinary
2016English

Dual Inhibition of DNA Polymerase PolC and Protein Tyrosine Phosphatase CpsB Uncovers a Novel Antibiotic Target

Biochemical and Biophysical Research Communications
BiochemistryCell BiologyMolecular BiologyBiophysics
2013English

Insights Into Novel Antimicrobial Compounds and Antibiotic Resistance Genes From Soil Metagenomes

Frontiers in Microbiology
Microbiology
2014English

Antibiotic Resistance: A Geopolitical Issue

Clinical Microbiology and Infection
MedicineInfectious DiseasesMicrobiology
2014English

Studies of Common Antibiotic Resistance-Associated Genes of Acinetobacter Baumannii

Vietnam Journal of Science, Technology and Engineering
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy